Table 2.
Screening, treatment and follow-up visits
| Screening | Baseline (before SBRT) | Mid of SBRT | End of SBRT | Follow-up | |||
|---|---|---|---|---|---|---|---|
| 6 weeks after SBRT | 1st year after SBRT: every 3 months | 2nd year after SBRT: every 6 months | |||||
| T0 | T1 | T2 | T3 | T4-7 | T8-9 | ||
| Medical history | x | x | x | x | x | ||
| EORTC QLQ-C30 and LMC21 | x | x | x | x | x | ||
| MR-Linac questionnaire (only treatment arm A) | x | x | |||||
| Documentation of medication | x | x | x | x | x | ||
| Documentation of Adverse Events | x | x | x | x | x | ||
| Case report form | x | x | x | x | x | ||
| Blood test | x | x | x | x | x | ||
| Breathhold assessment (> 25 s?) | x | ||||||
| MRI (c = contrast enhanced, n = without) | x (c) | x (n) | x (n) | x (c) | x (c) | x (c) | |